300813 泰林生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.9013.03513.92113.49414.370
总资产报酬率 ROA (%)0.6132.07510.09610.62511.993
投入资产回报率 ROIC (%)0.6512.22010.86811.6429.735

边际利润分析
销售毛利率 (%)44.89249.72152.58661.87862.868
营业利润率 (%)7.2998.07021.29424.64025.934
息税前利润/营业总收入 (%)8.2194.14618.99022.26522.517
净利润/营业总收入 (%)6.9266.83521.31322.42924.164

收益指标分析
经营活动净收益/利润总额(%)45.44526.62177.21884.68272.046
价值变动净收益/利润总额(%)0.000-0.0530.4513.5760.000
营业外收支净额/利润总额(%)1.2850.8980.419-0.215-0.393

偿债能力分析
流动比率 (X)4.9503.9485.9043.3524.475
速动比率 (X)3.7312.9555.0442.5543.812
资产负债率 (%)30.51733.20729.82724.16517.732
带息债务/全部投入资本 (%)26.75927.87625.26616.206--
股东权益/带息债务 (%)272.100257.202295.608511.871942.995
股东权益/负债合计 (%)227.287200.688235.263313.823463.968
利息保障倍数 (X)9.966-1.037-7.934-9.584-6.792

营运能力分析
应收账款周转天数 (天)37.54352.46839.02635.8140.000
存货周转天数 (天)317.253360.514237.246309.4620.000